Consider the case of Advanced Magnetics (AMAG) – a NASDAQ-listed technology company.

For years, AMAG's stock had been trading pretty flat. Most traders had written the stock off.

But then – in March 2005 – something extraordinary happened:

Most investors never saw this rapid move coming.

But, incredibly, you could have known about this movement MONTHS before anyone else.

How?

Thanks to the "glitch" I mentioned earlier. What happens is this:

In the case of Advanced Magnetics, the date was March 31, 2005.

Some in-the-know investors knew about this date more than 6 months in advance.

If you'd invested $5,000 in AMAG... you could have cashed out in 18 months with $44,650 in your pocket.

Of course, 2005 was smack dab in the middle of a raging bull market. So what about now?

How does this phenomenon stack up to a market depression like we're seeing today?

Well, take a look at Indevus, a tiny NYSE-listed company.

The government released a date -- June 27, 2008. Investors getting in after that date were able to follow Indevus on a rapid move up...

This was the same day the nation's largest savings and loan, Washington Mutual, failed and had to be seized by the FDIC. Shares of banks like Wachovia and National City dropped 40%.

In the subsequent week, the market as a whole lost a quarter of its value.

But, this phenomenon worked the same way it always does. You invest based on the date the government "glitch" spits out. Then sit and wait to collect your gains. Sometimes it happens in 18 months. Sometimes in three. But, you can always collect.

For instance:

Others have returned even more money...

Like Actelion (ATLN), which shot up 985%.

In fact, over the last 8 years, we've documented and analyzed 69 separate occurrences that were all affected by this government glitch.

On average, these occurrences – all 69 of them – crushed the Nasdaq by about 600%.

And, the best part is... you can know EXACTLY when these trades are going to be triggered...

Here's what I mean...

Dr. Huang knows about this situation from first-hand experience.

He's spent the better part of the past decade working in academic institutions, as a contractor with the U.S. government, and with private firms. In each position, he worked closely with the Federal agency involved in the glitch, and learned more about how the system works.

Along the way, he figured out an extraordinary way to make money.

I have to warn you:

When you read the full explanation, it will probably sound as if it may be illegal.

But I assure you, we've done an incredible amount of legwork on this situation. Dr. Huang has criss-crossed the country 5 times in the past year to check it out. And we've had our in-house counsel review the entire process with a fine-tooth comb.

So how does this government glitch work, exactly?

And sent to certain publicly traded U.S. companies...

This 6-story office building houses the Food and Drug Administration – commonly known as the FDA.

Every American knows about the FDA... to some extent.

They give final approval on nearly all new medical treatments in the U.S.

Of course, they give final approval of prescription drugs such as Lipitor and Celebrex. But that's just one small part of what the FDA does.

They regulate American food: Corn from the Midwest. Pork imported from China.

Commercial breakthroughs in nanotechnology.

Even cosmetics.

And herein lies our opportunity...

The "glitch" I've alluded to throughout this letter – and the greatest opportunity for you to make money over the next 5+ years...

You just write the date down... and watch the money roll in.

Here's how it works...

The FDA will tell you exactly when these letters will be sent. So you can actually mark the dates on your calendar, if you wish. (As you'll see in a few moments, we've prepared an internal model trading calendar with every single one of these dates. We'll give you access to a printable copy)

And if you buy shares in these companies SHORTLY AFTER the Complete Response letter arrives, you stand to make a fortune over the ensuing months.

Alkermes (ALKS) received a letter from the FDA on July 1, 2002. If you'd bought shares in advance, you could've been sitting on 267% returns by October the following year. Even more (563%) if you'd held on through 2006.

It happens again and again in this industry.

The FDA sends a one-page letter toward the end of its Review Process...

And in-the-know investors get rich:

	On Oct. 12, 2001, Amylin (AMLN) received an FDA Complete Response letter. Within 12 months, shares had jumped 104.7%... later rising more than 500%.
	On April 28, 2003, Noven (NOVN) received a Complete Response letter from the FDA. Within 12 months, early investors more than doubled their money... ultimately collected more than 800% before the stock finally slowed down.
	On June 2, 2004, Allos (ALTH) received their Complete Response letter from the FDA. The stock took off.... If you'd invested at the right time, you could have pocketed an easy 400% or more.

Dr. Huang's database contains dozens of examples much like these.

So... how do you know which companies are the best to buy... and when?

Let me explain...

At first, I was very skeptical. After all, I'd spent many years as a professional trader before joining S&A.

And I'd never heard of "COMPLETE RESPONSE LETTERS," or how easily one could make a fortune trading on them.

So I insisted that Dr. Huang walk me through dozens of examples... and show me exactly how it works, every step of the way.

And that's exactly what he's done over the past few months.

Dr. Huang showed me the results of his 8-year back-testing study – and the trading strategy he developed.

It is, hands down, one of the most incredible trading breakthroughs I've ever witnessed.

That's why I've sent this letter to you, specifically.

Dr. Huang and his team have created a trading research service based on this breakthrough phenomenon:

I believe it's in the best financial interest of S&A subscribers to utilize this strategy. And we want to make it as easy for you to try as possible.

Before I tell you what to expect from the plays Dr. Huang has lined up (he's been tracking 3 set to be triggered within the next 30 days)...

I should answer a question you've probably been asking:

If you really can make a fortune trading on these COMPLETE RESPONSE LETTERS... then why don't more people know about it?

For starters, very few analysts or traders anywhere in America have the expertise to understand this phenomenon...

Let alone to deconstruct it... to interpret the data on these letters properly... and to create a trading strategy that's not only very low-risk... but also 100% successful.

You see, the particular stocks this government "glitch" affects (predominately those in the healthcare sector) follow their own set of rules.

Their shares move in ways that defy typical financial analysis. That's why they're able to make money, no matter what the rest of the markets are doing.

Consider a company like Advanced Magnetics (AMAG), which I mentioned earlier.

In 2005, most traders down in the pits wouldn't have wiped the sweat off their brow with AMAG's balance sheet.

But if they'd known that AMAG's radically innovative nanotechnology would soon revolutionize diagnostic medicine in the US... they could have cashed in on the 893% profits AMAG's stock quickly generated.

Perhaps you can see why COMPLETE RESPONSE LETTERS remain such a secret. Very few folks are qualified to trade on them.

That brings me to another big reason you've likely never heard of this market situation until now...

Right now I have Dr. Huang's model trading calendar in front of me.

It lists every single company scheduled to receive one of these letters from the FDA -- all the way through June 2009.

Could every one of these trades rise in value? Sure, according to Dr. Huang's study, if you simply bought every stock that received a Complete Response letter, you could have made an average of 19% gains.

But Dr. Huang's only going to recommend a fraction of these opportunities to trade on – the ones with the best chance to make big moves, fast...

Why?

In short, because it's almost impossible to double your money or better in a short period of time, on a really big stock.

Consider: On July 18, 2006, drug giant Johnson & Johnson received a Complete Response letter from the FDA. And the stock gained about $15,120,000,000 in value. But for a large company like J&J, that equates to only an 8% move.

Not bad... but barely a blip when you compare it to a small company like NPS Inc (NPSP), which received a Complete Response letter around roughly the same time as J&J.

Shares of NPS surged 168% in roughly the same time.

That's why Dr. Huang focuses his attention on  the smallest companies in the market, with the potential for the biggest moves.

You see, Dr. Huang looks for the biggest possible returns over a 12-18 month period. He wants to help you to get in, get paid, and get out pretty quickly. The FDA REPORT is, after all, a trading research service.

So how much money can you expect to make with these FDA trades... and when is the next upcoming opportunity?

I'll explain everything in a minute. But first, I wanted to tell you about one more aspect of this situation.

You see... this opportunity with Complete Response Letters gets even better.

I knew you probably wouldn't believe if I told you this earlier...

But now that you know how this situation works... and have seen the proof for yourself...

Well, let me show you what I mean...

What sends these Complete Response Letter stocks soaring?

I won't spoil the secret here. You'll have immediate access to the full details on the Complete Response Letter from Dr. Huang's recently published FDA Report trading Primer.

Every new subscriber to our new FDA REPORT will receive access to this primer.

This is the very first thing you need to read if you want to take advantage of these trading recommendations. Inside, Dr. Huang explains in greater detail everything I've touched upon so far:

I'll stop right here. Very simply, the information it contains represents the most essential conclusions and secrets Dr. Huang spent more than a year uncovering...

As a new FDA REPORT subscriber, you can claim your copy today – in the next 30-90 minutes. Right on your computer.

Of course, Dr. Huang will also alert you to any separate, special opportunities in the biotech market, as well.

For instance, biotech innovator Imclone was the target of a takeover bid from Eli Lilly. Dr. Huang recommended a trade to take advantage of this situation and readers had a chance to make a 64% return in three weeks.

Read the primer as soon as you can. Dr. Huang does all the legwork. Once you're ready for a taste, all you have to do is write the Complete Response Letter dates down... and trade when he sends you an alert.

But read over this primer today. You'll want to be up to speed ASAP. There are 6 potential trades set to be triggered in the next 30 days.

The first is only days away...

How do you make these trades?

If Dr. Huang issues a "Buy," he'll send you an e-mail right away. Then, simply call up your broker, or log-on to your online brokerage account.

But please remember: Don't deviate from Dr. Huang's recommendation. If you choose to make take his recommendation, follow his guidance exactly.

You'll get the full details on his next play as soon as you become an FDA Report subscriber.

But before you rush out to invest in any of these recommended trades, for that matter – there's something vitally important you need to know...

If you buy shares AFTER a company receives a COMPLETE RESPONSE LETTER – INSTEAD OF BEFOREHAND – you make much more money.

How much more?

6-7-times more, on average.

So... how long after a company receives one of these letters should you wait before loading up on shares?

Well, I'm sure you'll understand — this information is reserved for subscribers only.

But don't worry.

Like I said, it's hands-off and easy for you to capitalize on. I won't say much more here... but just know Dr. Huang developed a timing indicator that lets him know EXACTLY when to buy shares in these government "glitch" opportunities.

You'll find everything you might want to know about Dr. Huang's strategy in the FDA REPORT primer.

Along with your FDA REPORT primer, you'll receive a copy of Dr. Huang's model trading calendar...

It's a master list of every letter scheduled for release between now and June 2009. And it's updated every month.

The companies set to receive them...

And the precise dates for each event.

To get started, here's what you do:

	FIRST, use Dr. Huang's master calendar to mark the dates.
	THEN, wait for Dr. Huang's email. He'll tell you whether or not to trade on each date you've marked down. Sometimes he'll wait only six or seven days. Other times he'll patiently wait for a month or two. Either way, he'll let you know what he's thinking, as he's thinking it.
	FINALLY, when Dr. Huang recommends you trade on a COMPLETE RESPONSE LETTER event... he'll send you an email, telling you exactly what you should say to your broker.

That's it.

Sounds ridiculously simple, I know. That's exactly why we're so excited at Stansberry and Associates about bringing you the FDA Report.

I have no doubt you can make money from Dr. Huang's recommendations... no matter WHAT the market is doing right now.

And since we're so sure that this new service will improve your net worth – and hopefully deepen our relationship – we'd like to extend you a very special offer.

The S&A FDA Report costs $2,400 for a one-year subscription, a price you could easily make back with Dr. Huang's next recommendation, coming before the end of this month...

And no matter what:

You'll have 90 DAYS to decide whether Dr. Huang's research is right for you. If for whatever reason you want to cancel your subscription in the first ninety days, just let us know. We'll give you a full refund.

So sign up today... and take the next 3 months to follow Dr. Huang's trades.

Here's what you'll receive as an FDA REPORT subscriber:

To take advantage of this unique opportunity, Subscribe Now

Sincerely,



Brian Hunt
Editor in Chief, S&A Research

P.S. If you're unsure about whether or not the FDA Report is right for you, I'd encourage you to take advantage of our 90-day, risk-free subscription. You can follow Dr. Huang's upcoming trade and if you find the FDA Report isn't what you're looking for, we'll be happy to give you a full refund, no questions asked, in the first three months.